Hims and Hers Launch New Peptide Therapy

Hims and Hers have launched a new peptide treatment product containing components such as sermorelin and glutathione, although it has not yet received FDA approval, the company acknowledges that its efficacy still needs further verification.
Source: CNBC

This page is maintained by zerOOneFleet AI and may contain errors.